Market Size of Mice Model Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 1.5 Billion |
| Market Size (2029) | USD 2.80 Billion |
| CAGR (2024 - 2029) | 6.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Mice Model Market Analysis
The Mice Model Market size is estimated at USD 1.5 billion in 2024, and is expected to reach USD 2.80 billion by 2029, growing at a CAGR of 6.80% during the forecast period (2024-2029).
The mice model market is expected to register a CAGR of 6.8% over the forecast period. The COVID-19 pandemic had a significant impact on the market studied. Research laboratories and biopharmaceutical industries extensively used mice models in preclinical development. For instance, according to an article published by Methods of Molecular Biology in October 2022, a small rodent animal model using K18 hACE2 transgenic mice was presented as an option for understanding the pathogenicity of natural SARS-CoV-2 strains. Thus, the adoption of mouse models to analyze the progress made since the discovery of SARS-CoV-2 in developing and applying relevant mouse models had been anticipated to drive market growth during the pandemic. However, as the COVID-19 cases started to decline, the market had begun to show average pre-pandemic level growth and was likely to continue its significant growth rate during the forecast period.
Factors such as increasing innovations in mice models, rising demand for personalized medicine, and a growing pipeline of pharmaceutical and biopharmaceutical companies are driving the growth of the mice model market. For instance, an article published by Molecular Neurodegeneration in June 2022 stated that the genetic engineering of novel mouse models using knock-in approaches addresses some of the limitations of genetic mutations. Also, the article mentioned in its conclusion that the scientific community should use the open-access mouse model as a resource to study disease-relevant biology. Thus, such instances are anticipated to boost the demand for mice models, further driving the market growth.
In addition, the rising demand for precision medicine is driving the growth. For instance, in April 2022, an article published in the journal Nature Medicine reported that the increasing use of genomic profiling for diagnosis and therapy guidance in many tumor types had increased the use of precision medicine in cancer patients. With the increased demand for precision medicine, the utilization of mouse models will also increase, leading to market growth.
Furthermore, several key market players have also been investing in the market's growth. For instance, in January 2022, Inotiv acquired Orient BioResource Center, Inc. from Orient Bio, Inc., a preclinical CRO and animal model supplier based in Seongnam, South Korea. Orient BioResource Center is a primate quarantine & holding facility located near Alice, Texas.
Hence, as per the abovementioned factors, the mice model market is anticipated to grow over the forecast period. However, alternatives to animal testing and regulations for the ethical use of animals are expected to restrain the market's growth.
